EntryPoint Capital’s Health Catalyst HCAT Stock Holding History

EntryPoint Capital’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,768	Closed	-$89.6K	–	764
2025 Q2	$89.6K	Buy	+23,768	New	+$93.5K	0.04%	568
2024 Q3	–	Sell	-1,001	Closed	-$6.4K	–	917
2024 Q2	$6.4K	Sell	1,001 -12,016	-92%	-$77.1K	﹤0.01%	1316
2024 Q1	$98K	Buy	+13,017	New	+$119K	0.09%	432

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

EntryPoint Capital's HCAT Position: Q3 2025 in Review

EntryPoint Capital sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 23,768 shares — an estimated $89.6K sold.

EntryPoint Capital first reported a position in HCAT in Q1 2024 and held it in 3 quarters. The position peaked at $98K in Q1 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

EntryPoint Capital reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
EntryPoint Capital sold 23,768 Health Catalyst shares in Q3 2025, an estimated $89.6K.
EntryPoint Capital first reported a position in Health Catalyst in Q1 2024 and held it in 3 quarters.
EntryPoint Capital's Health Catalyst position peaked at $98K in Q1 2024.
145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on EntryPoint Capital's 13F filing for Q3 2025, filed 13 Nov 2025.